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Abstract: Introduction: Aerosolgenerating procedures (AGPs) put
the dental health care professionals
(DHCPs) at a greater risk for acquiring
severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection.
In late June 2020, the Centers for
Disease Control and Prevention
advised elective dental procedures
provision to asymptomatic patients
while mandating strict infection
control protocol and suggested the
use of preprocedural testing as an
adjunct. A cost-effective method for
mass preprocedural testing is pool
testing, which has specificity and
sensitivity similar to polymerase chain
reaction. This article aims to assess the
outcomes and utility of incorporating
preprocedural testing protocol for
SARS-CoV-2 in dental clinics before
providing AGPs.
Method: The patients who were
recommended AGPs where rubber
dam placement was not possible were
advised to undergo preprocedural
testing for SARS-CoV-2. Pool testing
strategy was employed, and patients
were asked to get tested 48 h before the
day of the procedure.

Results: Out of a total of 1,000
patients, who presented from June
2020 to late July 2020, 464 were
recommended dental procedures.
In 194 of 464, AGPs could not be
performed under rubber dam isolation;
therefore, the patients were advised to
get a preprocedural pool test. In total,
111 patients deferred the procedure
and testing. Out of 83 who got tested,
7 were positive for SARS-CoV-2, 5 of
whom were tested in early June 2020
and 2 in late July 2020.

they wish to use when performing
aerosol-generating procedures
in asymptomatic patients with
consideration of cost sensitivity and
specificity values.

Conclusion: Pool testing within
its limitations can be a useful
preprocedure test in asymptomatic
low-risk patients for AGP in dentistry,
especially when the disease prevalence
is low or moderate (<10%). It has the
potential of reducing testing costs
significantly while conserving reagent
and other resources. Preprocedure
testing, however, also gives rise to
certain ethical concerns that also need
to be addressed.

Severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) was declared
a global pandemic in March 2020,
and since then, it has claimed millions
of lives and trillions of dollars. Many
countries had to impose lockdown for
approximately 7 wk to slow the virus
spread, but this negatively affected the
economy in all sectors, especially the
health care sector (Emanuel et al. 2020).
The most commonly known SARSCoV-2 transmission route is through
inhalation of respiratory droplets or
aerosols from infected individuals (Jamal
et al. 2020). In the dental clinic, aerosols
are generated during dental procedures
as a result of water irrigation for cooling
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of the dental handpieces and ultrasonic
devices (Epstein et al. 2020). Furthermore,
high viral loads have been found in
the saliva of both symptomatic and
asymptomatic infected patients. Thus, the
dual effect of aerosol generation along
with saliva and the fact that dental work
requires close proximity and prolonged
contact time leaves dental health care
providers (DHCPs) particularly vulnerable
to contract coronavirus disease 2019
(COVID-19) infection (Jamal et al. 2020).
This led to confinement of dental work to
emergency management only to reduce
the risk of cross-infection, consequently
leading to grave monetary losses in the
dental practices (Schwendicke et al.
2020).
Pakistan received positive confirmation
of SARS-CoV-2 cases in February
2020, which eventually led to strict
lockdown enforcement (Tariq et al.
2020). However, during late May 2020,
many countries, including Pakistan,
eased lockdown restrictions, allowing
the return of workflow to normalcy. This
facilitated elective treatment in dentistry
per Centers for Disease Control and
Prevention (CDC) guidelines, which
further suggested that “facilities can
consider implementing preadmission
or preprocedure diagnostic testing for
SARS-CoV-2” (https://www.cdc.gov/
coronavirus/2019-ncov/hcp/dentalsettings.html).
This preprocedural testing is
important because an asymptomatic/
presymptomatic patient poses the
greatest risk of contagion, especially
while providing aerosol-generating
procedures (AGPs) (Lauer et al. 2020).
An ideal preprocedural test should be
cost-effective, highly sensitive, and easy
to perform, and it should generate rapid
results. For SARS-CoV-2 diagnosis, realtime reverse transcription polymerase
chain reaction test (RT-PCR) is the goldstandard test that is performed using
respiratory samples. However, RT-PCR
testing is expensive, time-consuming, and
requires specialized infrastructure (Wu et
al. 2020). A single RT-PCR test may cost
approximately $41 in Pakistan and the
United States (Mahony et al. 2004). Other
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alternative methods for preprocedure
testing are antigen and antibody tests,
which, although rapid, may suffer from
suboptimal sensitivity (36.4%) (Pan
et al. 2020). Furthermore, antibodies
may take up to 12 to 14 d to develop;
hence, the efficacy of the antibody test is
reduced in the acute phase of infection
when the patient is asymptomatic/
presymptomatic and therefore has
limited use as a preprocedural test in
asymptomatic patients (Zhao et al. 2020).
In contrast, the latest literature on pool
sampling for COVID-19 screening has
shown promising results with sensitivity
values of 91%, which is close to RT-PCR
(Mutesa et al. 2020). Furthermore, the
pool testing strategy offers the advantage
of reduced operational costs in certain
circumstances by up to 20-folds while
preserving reagents as well as specialized
human resources (Mutesa et al. 2020).
However, pool testing inherits all the
aforementioned disadvantages of being
an RT-PCR–based test.
Due to the low costs it offers to
the patients while maintaining high
sensitivity, it was decided that all those
patients requiring surgical procedures
under general anesthesia and AGPs
without a rubber dam in dentistry would
be required to undergo preprocedure
pool testing.
It seems unlikely that an infected
symptomatic individual would seek
elective dental care, and therefore,
the biggest challenge our profession
faces is the risk of getting infected
by asymptomatic spreaders. With the
COVID-19 cases perpetually increasing, it
is imperative in order for our profession
to thrive that we come up with neoteric
solutions to counter this hazard. In this
communication, we have highlighted the
concept of the pool testing, which was
strategically used as a preprocedural test
for patients requiring elective AGPs.
Method
The dental clinic at our tertiary
care hospital started elective dental
treatment on May 28, 2020. Non- AGPs
were carried out if the patient was
asymptomatic after initial screening,

and AGPs were done under rubber dam
isolation. This was allowed because
it has been demonstrated that rubber
dam isolation can decrease aerosol
generation by up to 70% within a 3-foot
radius (Jamal et al. 2020). However,
preprocedural testing was mandatory
in procedures such as crown cutting,
endodontic surgery, surgical extractions,
and other AGPs in which rubber dam
isolation was not feasible (Umer and
Motiwala 2020).
The patients were counseled about the
usefulness of preprocedure testing and
asked to get the test done 48 h before
the procedure. After the test was done,
patients were asked to self-isolate for
2 d. To ensure cost-effective and reliable
preprocedural testing, we employed the
“pool testing” strategy.
To get tested, the patient was given
an option of an appointment at the
centralized hospital testing site or, if they
had privacy or any other concerns, they
could opt for at-home testing service
for an additional service fee. Pooling
samples were compiled on a first come,
first serve basis in a central biosafety
level III laboratory. The pool size was
internally validated according to US Food
and Drug Administration (FDA) policy
for the COVID-19 test (https://www
.fda.gov/media/135659/download), and
each pool consisted of 6 samples (6:1
ratio) collected as nasopharyngeal swabs
(Hogan et al. 2020).
These samples were stored at 4°C
before processing for virus isolation
and nucleic acid detection purposes.
Furthermore, each specimen went
through a process of batch organization
and was given dual identification
and a barcode through an electronic
lab tracking system. They were also
manually registered in the logbook so
that samples were not mixed.
The test was run on a Cobas SARSCoV-2, based on fully automated sample
preparation (nucleic acid extraction
and purification), followed by PCR
amplification and detection. Selective
amplification of target nucleic acid from
the samples was achieved by the use
of target-specific forward and reverse
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Figure. Workflow for preprocedure testing. *AGPs (aerosol-generating procedures) include crown cutting, surgical extraction, and
scaling and polishing and have to be performed without a rubber dam.

Low risk asymptomatic patients
undergoing AGPs* require preprocedural testing

Patient asked
to maintain
self isolation
for 10 days

AGPs will be
carried out after
pre-procedural
testing as per
CDC guidelines

Patients from all departments of
the hospital are referred to one
site for COVID-19 testing

PATIENT POSITIVE
FOR COVID-19
• Patient informed
• Primary team informed
• Treatment deferred

AGPs carried
out as per CDC
guidelines.

primers for ORF1 a/b nonstructural
region that is unique to SARS-CoV-2.
In addition, a conserved region in the
structural protein envelope E-gene was
chosen for pan-Sarbecovirus detection.
The pan-Sarbecovirus detection sets also
detect the SARS-CoV-2 virus. Finally, the
sample was stored for another 48 h after
reporting before being discarded.
According to the Dorfman algorithm,
if the pool tests are negative, then all
individuals in that pool have been
efficiently tested with a single test,
allowing conservative usage of reagents
and finances, with results posted in
24 h (Wacharapluesadee et al. 2020).
However, in the case of positive pool
tests, at least 1 person in the group
is tested positive for the disease, and
each sample from the pool needs an
additional test using RT-PCR. This added
a delay of 24 h (Wacharapluesadee et al.
2020), and therefore all the patients were
scheduled for dental procedures after
48 h from the date of the test (Figure).

Nasopharyngeal
swabs are taken for
COVID-19 testing

Each sample
tested again
separately with
PCR test.

No further
testing
required
Primary Team
informed

6 samples are pooled together for
testing, stored at 4 degree
centigrade

Pool
COVID-19
Positive

PCR MACHINE

Sample
stored for
further 48
hours after
testing

Pool
COVID-19
Negative

Results
From May 28, 2020, to July 20, 2020,
a total of 1,000 patients had visited the
dental clinics. Out of these, 536 patients
received consultation only. Procedures
were recommended for 464 patients,
which included non-AGPs, AGPs under
rubber dam isolation, and AGPs after
preprocedural testing (Table). Out
of 464 procedures, 270 patients had
undergone treatment without the need
for preprocedural testing (AGPs under
rubber dam isolation and non-AGPs),
whereas 194 (out of 464) patients were
advised AGPs in which rubber dam
placement was not feasible, and hence
preprocedural testing was recommended.
Out of these 194 patients, 111 patients
chose not to get preprocedural testing,
and the remaining 83 got testing done,
out of whom 76 patients tested negative
and 7 tested positive for SARS-CoV-2.
The rate of infection varied in the early
and late halves of June 2020. Between

Selective amplification of
target nucleic acid by use of
target-specific forward and
reverse primers for ORF1
a/b non-structural region

May 28 and June 15, 2020, of the 40
patients advised preprocedure testing,
14 patients opted not to get tested
and 26 got tested. Consequently, 21
tested negative and 5 tested positive for
SARS-CoV-2.
From June 16 to July 20, 2020, the
influx of patients had increased, and a
total of 154 patients were recommended
dental procedures, including AGPs and
non-AGPs. Out of these, a total of 57
patients got tested; 55 were negative
and only 2 tested positive. The overall
positivity rate of the tests done during
this period was 6.7%.
Discussion
The concept of “pool testing” was
introduced by Robert Dorfman in 1943
and has been used since for screening
infectious diseases (e.g., influenza virus,
hepatitis B virus, hepatitis C virus, and
human immunodeficiency virus [HIV])
(Hogan et al. 2020). It is a form of

3

Month 2021

JDR Clinical & Translational Research

Table.
Summary of the AGPs, Non-AGPs, and Preprocedural Testing until July 20, 2020.
From May 28 to
June 15, 2020

From June 16
to July 20, 2020

Total No.

Patients who received consultation only

187

349

536

Procedures recommended

198

266

464

Patients provided non-AGPs and AGPs (no pretestinga)

108

162

270

Patients who were advised pretestinga

40

154

194

Patients who got tested and were provided AGPs

26

57

83

5

2

7

19.2

3.5

6.7

Characteristic

Patients who tested positive for SARS-CoV-2 (managed as per CDC guidelines)
Infection rate at AKUH, %

AGP, aerosol-generating procedure; AKUH, Aga Khan University Hospital; CDC, Centers for Disease Control and Prevention; SARS-CoV-2, severe acute respiratory
syndrome coronavirus 2.
a
Pretesting of sample pooling was advised and tracked.

group testing, which nowadays is used
as a screening tool to identify low-risk
or asymptomatic SARS-CoV-2 patients
(Hogan et al. 2020).
The aim of this policy development
at the dental clinic of our university
hospital was to devise a strategy to
ensure maximum care to the patients
while conserving personal protective
equipment (PPE) and minimizing the
infection rate among DHCPs who are
directly involved in providing patient
care. To the best of our knowledge,
this strategy has previously been
researched for population screening
and epidemiological surveys but not
as a preprocedural protocol (Hogan
et al. 2020). According to our findings,
preprocedural testing allowed us to
provide safe elective dental treatment
to our patients during the pandemic.
We were also successful in curtailing
transmission of the infection to dentists
and auxiliary staff, especially in June
2020, when the national infection rate
was at its peak. This had a considerable
impact on the prevention of infection
in the dental department at Aga
Khan University Hospital, where the
nosocomial infection rate was maintained
to zero (Umer 2020b).
“Pool testing” also addressed patients’
financial concerns, as the pool testing
method provides sensitivity similar to the
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RT-PCR test, with a total cost of $17 at
our testing site. The cost of a single pool
test is approximately one-third of the total
cost for the RT-PCR test at our center. This
cost can further decrease by 20-fold with
a larger pool size (Mutesa et al. 2020).
Furthermore, this strategy conserves
reagents and the workforce required for
testing without overloading the system
in a resource-restrained environment
(Wacharapluesadee et al. 2020).
Elective dental treatment was deferred
in case the patient tested positive
for SARS-CoV-2. These patients are
further asked to meet with SARS-CoV-2
monitoring staff, who provided them
with basic knowledge, understanding,
and particulars of care for the infected
individuals. The hospital also had the
provision of a negative pressure room
equipped with a portable dental unit
should there be a need to treat a COVID19–positive patient for emergency dental
work (Umer 2020a).
The patients who opted not to get
tested were contacted at a later date over
the phone and were asked reasons for
not getting tested. The most common
reason stated was the fear of getting
a positive test result. This behavior is
commonly known as willful ignorance
or strategic ignorance, in which patients
avoid medical diagnosis for the fear of
social costs (14-d isolation, stigma, and

opportunity cost), which outweigh any
benefits of testing. This behavior is also
seen in patients with other diseases like
HIV or breast cancer (Thunström et al.
2020).
The major limitation of employing pool
testing is that it is a type of PCR test with
similar disadvantages, such as it is timeconsuming and requires a high level
of PPE and skilled staff to cater to the
amplified risk of infection that comes
along with collecting the nasopharyngeal
samples (Pan et al. 2020).
Another limitation of our strategy is
that the sensitivity and specificity of pool
testing were not scrutinized as a head-tohead comparison against gold-standard
RT-PCR, as we do not know if sample
pooling causes a dilution effect that may
negatively affect the diagnostic validity
of the test. To investigate this uncertainty,
further diagnostic validity studies are
required comparing RT-PCR with pool
testing. Only 1 study is known to us that
conducted a head-to-head comparison and
did not find any difference between the
pool test and RT-PCR in terms of sensitivity
values, but the study was underpowered
(Wacharapluesadee et al. 2020).
This protocol also raises a few ethical
concerns as a false-negative result may
subject the DHCPs to a false sense of
security and an increased chance of
exposure. In case of a false positive, the
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patient may require further unneeded
testing and/or may need to undergo selfisolation and anxiety.
In our strategy, false negatives were
considered true negatives as we did not
subject our samples to further testing
knowing that a false-negative rate of
RT-PCR may range from 2% to 28%
(sensitivity of 71%–98%). Therefore,
it would be fair to assume that pool
testing would also have a similar falsenegative rate, if not worse, and we
recommend that even with negative pool
test results, the DHCPs should follow
appropriate PPE protocol (Umer et al.
2020). However, we did have a default
mechanism to check for false positives in
which a pool with a positive result was
rechecked with an individual RT-PCR.
Considering that an RT-PCR has high
specificity, it would be fair to assume
that our positive pool test was a true
positive (Watson et al. 2020).
Preprocedural pool testing strategy
works best when the disease prevalence
is low or moderate and the number of
samples in the pool is determined by
the disease prevalence; it might not be a
useful protocol when disease prevalence
is high (Wacharapluesadee et al. 2020).
This is because low disease prevalence
allows batching a larger pool size. As the
prevalence increases, the positivity rate
within the pool also increases, and thus
the cost-saving benefit of pooling may be
negated as the positive pool batches will
be required to be retested. Therefore,
the CDC recommends that laboratories
should monitor disease prevalence
according to their positivity rate over
the previous 7 to 10 d and accordingly
adjust pool sizes (https://www.cdc.gov/
coronavirus/2019-ncov/lab/poolingprocedures.html).
According to a study published in the
American Journal of Clinical Pathology,
pool testing can be a useful and costsaving strategy as long as the incidence
of SARS-CoV-2 infection remains below
10%, and in our study, the positivity rate
was 6.7% (Abdalhamid et al. 2020).
A further limitation of our study is that
we know that COVID-19 infection may
cause prolonged RNA shedding even
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when the patients are not infectious
anymore. We did not account for any
misclassification of our cases, who could
have been postsymptomatic (Xu et al.
2020).
An ethical implication of the
preprocedure COVID-19 test is if a
patient tests positive, how will the
individual privacy be maintained? Of
course, the dental team prescribing
the test needs to be prompted by a
positive test outcome so that the planned
procedure can be deferred to a later
date. At our institution, by law, we
were obliged to share this information
with the government, because to
mitigate the spread of COVID-19, an
early response was critical. Right now,
such a response may be justified as we
are trying to contain this pandemic.
However, in the long run, it can give
rise to complex individual privacy
issues; hence, the legislature will be
required to use aggregate data rather
than individual data so that they are
not misused. Meanwhile, at a practice
level, we recommend that best practice
according to local laws be identified
and maintained for responsible use of
such information. In our institution, for
example, personnel assigned to inform
and follow up positive patients were
public health experts allocated by the
local government and were legally
bound to government data protection
regulations.
Another ethical question that may arise
is, if the patient refuses preprocedural
testing, can the DHCPs refuse to
do AGPs, especially if it is a dental
emergency? Is it as simple as saying “no
mask, no service”? This concern has not
been answered, and when we joined
this profession, we accepted a certain
degree of risk associated with the trade.
Therefore, refusing treatment to patients
who opt not to get tested is an idea
that may or may not get support from
bioethics experts.

asymptomatic low-risk patients for
AGPs in dentistry, especially when the
disease prevalence is low or moderate
(<10%). It has the potential of reducing
testing costs significantly while
conserving reagent and other resources.
Preprocedure testing, however, also gives
rise to certain ethical concerns that also
need to be addressed.

Conclusion

Emanuel EJ, Persad G, Upshur R, Thome
B, Parker M, Glickman A, Zhang C,
Boyle C, Smith M, Phillips JP. 2020. Fair
allocation of scarce medical resources

Pool testing within its limitations
can be a useful preprocedure test in
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